Corporate Banner
Satellite Banner
Technology
Networks
Scientific Communities
 
Become a Member | Sign in
Home>News>This Article
  News
Return

Microsaic to Launch New Chip-based Mass Spectrometry Instrument at Pittcon 2013

Published: Monday, January 07, 2013
Last Updated: Sunday, January 06, 2013
Bookmark and Share
Only instrument of its type based on MEMS technology makes US debut.

Microsaic Systems plc will showcase its new revolutionary chip-based technology for the first time on booth #2255 at PITTCON 2013, from March 17 - 21, 2013 at the Pennsylvania Convention Center, Philadelphia.

Microsaic Systems is the only producer of mass spectrometry instrumentation using Micro-Electrical-Mechanical Systems (MEMS) technology.

The significant and innovative advances in the new chip-based instrument, the Microsaic 4000 MiD, offers a redesigned unit with an even smaller footprint.

Microsaic Systems is the first and only company to have commercialized MS (mass spectrometry) technology on a chip based on MEMS technology originating at the highly regarded Optical and Semiconductor Devices Group at Imperial College London.

The company’s breakthrough product, the 3500 MiD launched in January 2011, represented a step change in the ease of use and footprint of mass spectrometry.

The instrument won an R&D 100 award from an independent judging panel and the editors of R&D magazine due to it being smaller, lighter, consuming less energy, easier to maintain and cheaper to run than conventional MS systems.

The Microsaic 4000 MiD is the culmination of over a decade of research, bringing together two high tech fields - chemical analysis and silicon micro-engineering - to make possible a transformative capability in detection.

Its low operating cost and small footprint make the instrument deployable in a wide range of applications where mass spectrometry has not been able to reach - until now.

The next generation of the chip-based technology to make its US debut at Pittcon 2013 is now even smaller. As a result the Microsaic 4000 MiD fits even more comfortably into a standard lab fume hood, opening up further opportunities in the field of reaction monitoring.

Users are able to increase the use of mass spectrometry in the lab, while benefiting from significant cost savings, owing to fewer necessary structural components such as gas generators and air conditioning.

There are also sizeable savings with the use of ‘Plug and Play’ components which enable users to maintain the system themselves, resulting in less downtime and greater flexibility within the laboratory.

“With the premier launch of the Microsaic 4000 MiD and future plans for our growing portfolio of chip-based technology, the Microsaic exhibit at PITTCON will demonstrate how we work with and enable our customers to improve their laboratory operations,” said Colin Jump, CEO, Microsaic Systems.

Jump continued, “Offering the smallest footprint in the market, the Microsaic 4000 MiD is a fully integrated, versatile, portable MS system designed for bench chemists. The core technologies are chip-scale versions of traditional mass spec components which can be interchanged rapidly by the user. This modular approach allows users to maintain the system without the need for expensive service contracts and time-consuming call-outs.”


Further Information
Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 2,500+ scientific posters on ePosters
  • More Than 3,700+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

Microsaic Systems Signs Commercial Agreement
Second major agreement for novel miniaturized chip-based scientific instrument.
Thursday, April 11, 2013
Microsaic Systems Appoints Colin Jump as New CEO
Company to drive the commercialization of its revolutionary chip-based technology.
Tuesday, November 06, 2012
Microsaic Systems Wins R&D 100 Award for the World’s Most Compact Mass Spectrometer
Microsaic’s 3500 MiD mass spectrometer has been chosen winner by an independent judging panel and the editors of R&D Magazine.
Friday, June 22, 2012
Microsaic Systems Appoint Sales and Marketing Manager
Microsaic Systems plc announces that Samantha Dunnage has joined to lead the Company’s marketing and direct sales.
Monday, August 08, 2011
Microsaic Systems - First-to-market Developer of Miniaturized Chip-based Scientific Instruments
Microsaic Systems plc, has announced that it has raised gross proceeds of £4 million by way of an institutional placing in connection with the forthcoming admission of its shares to trading on the AIM market of the London Stock Exchange.
Wednesday, April 06, 2011
Scientific News
The Changing Tides of the In Vitro Diagnostics Market
With the increasing focus in personalized medicine, diagnostics plays a crucial role in patient monitoring.
LaVision BioTec Reports on the Neuro Research on the Human Brain After Trauma
Company reports on the work of Dr Ali Ertürk from the Institute for Stroke and Dementia Research at LMU Munich.
NIH Study Shows No Benefit of Omega-3 Supplements for Cognitive Decline
Research was published in the Journal of the American Medical Association.
Less May Be More in Slowing Cholera Epidemics
Mathematical model shows more cases may be prevented and more lives saved when using one dose of cholera vaccine instead of recommended two doses.
Investigating the Vape
Expert independent review concludes that e-cigarettes have potential to help smokers quit.
NIH Launches Human RSV Study
Study aims to understand infection in healthy adults to aid development of RSV medicines, vaccines.
Researchers Discover Synthesis of a New Nanomaterial
Interdisciplinary team creates biocomposite for first time using physiological conditions.
Poor Survival Rates in Leukemia Linked to Persistent Genetic Mutations
For patients with an often-deadly form of leukemia, new research suggests that lingering cancer-related mutations – detected after initial treatment with chemotherapy – are associated with an increased risk of relapse and poor survival.
Flu Remedies Help Combat E. coli Bacteria
Physiologists from the University of Zurich have now discovered why the intestinal bacterium Escherichia coli (E. coli) multiplies heavily and has an inflammatory effect.
Marijuana Genome Unraveled
A study by Canadian researchers is providing a clearer picture of the evolutionary history and genetic organization of cannabis, a step that could have agricultural, medical and legal implications for this valuable crop.
Scroll Up
Scroll Down
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,500+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
3,700+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FREE!